435 related articles for article (PubMed ID: 19326464)
21. Salmonella/human S9 mutagenicity test: a collaborative study with 58 compounds.
Hakura A; Shimada H; Nakajima M; Sui H; Kitamoto S; Suzuki S; Satoh T
Mutagenesis; 2005 May; 20(3):217-28. PubMed ID: 15843387
[TBL] [Abstract][Full Text] [Related]
22. Contamination is a frequent confounding factor in toxicology studies with anthraquinone and related compounds.
Butterworth BE; Mathre OB; Ballinger KE; Adalsteinsson O
Int J Toxicol; 2004; 23(5):335-44. PubMed ID: 15513832
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of the protective effects of quercetin in the hepatopulmonary syndrome.
Tieppo J; Vercelino R; Dias AS; Silva Vaz MF; Silveira TR; Marroni CA; Marroni NP; Henriques JA; Picada JN
Food Chem Toxicol; 2007 Jul; 45(7):1140-6. PubMed ID: 17306429
[TBL] [Abstract][Full Text] [Related]
24. An evaluation of 55 commercial plant extracts in the Ames mutagenicity test.
Schimmer O; Krüger A; Paulini H; Haefele F
Pharmazie; 1994 Jun; 49(6):448-51. PubMed ID: 8047546
[TBL] [Abstract][Full Text] [Related]
25. Genotoxic evaluation of extracts from Aplysina fulva, a Brazilian marine sponge.
Aiub C; Giannerini A; Ferreira F; Mazzei J; Stankevicins L; Lobo-Hajdu G; Guimarães P; Hajdu E; Felzenszwalb I
Mutat Res; 2006 Dec; 611(1-2):34-41. PubMed ID: 16987694
[TBL] [Abstract][Full Text] [Related]
26. Antimutagenic and antioxidant/prooxidant activity of quercetin.
Geetha T; Malhotra V; Chopra K; Kaur IP
Indian J Exp Biol; 2005 Jan; 43(1):61-7. PubMed ID: 15691067
[TBL] [Abstract][Full Text] [Related]
27. Intermediate frequency magnetic fields do not have mutagenic, co-mutagenic or gene conversion potentials in microbial genotoxicity tests.
Nakasono S; Ikehata M; Dateki M; Yoshie S; Shigemitsu T; Negishi T
Mutat Res; 2008 Jan; 649(1-2):187-200. PubMed ID: 17997348
[TBL] [Abstract][Full Text] [Related]
28. The effectiveness of Salmonella strains TA100, TA102 and TA104 for detecting mutagenicity of some aldehydes and peroxides.
Dillon D; Combes R; Zeiger E
Mutagenesis; 1998 Jan; 13(1):19-26. PubMed ID: 9491389
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of pyrogallol-induced cytotoxicity in catalase-mutant escherichia coli and mutagenicity in Salmonella typhimurium.
Takemura Y; Wang DH; Sauriasari R; Horita M; Tsutsui K; Sano K; Masuoka N; Takigawa T; Takaki J; Ogino K
Bull Environ Contam Toxicol; 2010 Mar; 84(3):347-50. PubMed ID: 20101387
[TBL] [Abstract][Full Text] [Related]
30. The anti-mutagenic and antioxidant effects of bile pigments in the Ames Salmonella test.
Bulmer AC; Ried K; Coombes JS; Blanchfield JT; Toth I; Wagner KH
Mutat Res; 2007 May; 629(2):122-32. PubMed ID: 17350329
[TBL] [Abstract][Full Text] [Related]
31. Bacterial photomutagenicity testing: distinction between direct, enzyme-mediated and light-induced events.
Utesch D; Splittgerber J
Mutat Res; 1996 Sep; 361(1):41-8. PubMed ID: 8816942
[TBL] [Abstract][Full Text] [Related]
32. Mutagenic activity of 3,6-diamino-10-methyl-9,10-dihydroacridine in Salmonella typhimurium cells.
Ferenc T; Janik-Spiechowicz E; Bratkowska W; Denys A
Int J Occup Med Environ Health; 1999; 12(1):67-72. PubMed ID: 10360086
[TBL] [Abstract][Full Text] [Related]
33. Collaborative study of interlaboratory variability in Salmonella typhimurium TA102 and TA2638 and Escherichia coli WP2/pKM101 and WP2 uvrA/pKM101. Association of Microbial Mutation Testing Laboratory C.O.
Watanabe K; Sakamoto K; Sasaki T
Mutagenesis; 1995 May; 10(3):235-41. PubMed ID: 7545260
[TBL] [Abstract][Full Text] [Related]
34. In vitro mutagenicity and metabolism of the cycloaliphatic epoxy Cyracure UVR 6105.
Kostoryz EL; Smith RE; Glaros AG; Chappelow CC; Eick JD
Mutat Res; 2004 Sep; 563(1):25-34. PubMed ID: 15324746
[TBL] [Abstract][Full Text] [Related]
35. Standardization of conditions for the metabolic activation of N-nitrosodiethylamine in mutagenicity tests.
Aiub CA; Pinto LF; Felzenszwalb I
Genet Mol Res; 2004 Jun; 3(2):264-72. PubMed ID: 15266397
[TBL] [Abstract][Full Text] [Related]
36. Mutagenicity of antiviral substances of nucleobase analogue type in Salmonella typhimurium employing metabolic activation by mouse liver homogenate or cell-free plant extracts.
el-Tarras A; Braun R; Stenz E; Schuster G
Zentralbl Mikrobiol; 1989; 144(3):191-6. PubMed ID: 2672681
[TBL] [Abstract][Full Text] [Related]
37. Lack of mutagenicity of stevioside and steviol in Salmonella typhimurium TA 98 and TA 100.
Klongpanichpak S; Temcharoen P; Toskulkao C; Apibal S; Glinsukon T
J Med Assoc Thai; 1997 Sep; 80 Suppl 1():S121-8. PubMed ID: 9347659
[TBL] [Abstract][Full Text] [Related]
38. Mutagenicity, antioxidant potential, and antimutagenic activity against hydrogen peroxide of cashew (Anacardium occidentale) apple juice and cajuina.
Melo Cavalcante AA; Rubensam G; Picada JN; Gomes da Silva E; Fonseca Moreira JC; Henriques JA
Environ Mol Mutagen; 2003; 41(5):360-9. PubMed ID: 12802807
[TBL] [Abstract][Full Text] [Related]
39. A 50 Hz, 14 mT magnetic field is not mutagenic or co-mutagenic in bacterial mutation assays.
Nakasono S; Ikehata M; Koana T; Saiki H
Mutat Res; 2000 Nov; 471(1-2):127-34. PubMed ID: 11080668
[TBL] [Abstract][Full Text] [Related]
40. Role of copper and ceruloplasmin in oxidative mutagenesis induced by the glutathione-gamma-glutamyl transpeptidase system and by other thiols.
Stark AA; Glass GA
Environ Mol Mutagen; 1997; 29(1):63-72. PubMed ID: 9020309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]